Applications of the PLSCR Family in Cell Death, Coagulation, and Inflammatory Signaling Research
Applications of the PLSCR Family in Cell Death, Coagulation, and Inflammatory Signaling Research
The PLSCR family is commonly used to study changes in membrane phospholipid asymmetry, phosphatidylserine (PS) externalization, cell death, platelet procoagulant activation, and inflammatory stress responses. In experiments, PLSCR expression changes, membrane localization changes, PS externalization, and specific pathway-driving mechanisms should be distinguished to avoid directly equating a single indicator with cell death or altered coagulation function.
Keywords: PLSCR family; PLSCR1; phospholipid scramblase; phosphatidylserine; PS externalization; cell death; apoptosis; platelet activation; coagulation; inflammatory signaling; interferon response
1 Research Background of Membrane Phospholipid Asymmetry and the PLSCR Family
1.1 Biological Significance of Membrane Phospholipid Asymmetry
The lipid distribution on the two leaflets of the normal plasma membrane is asymmetric. PS and phosphatidylethanolamine are mainly located on the inner leaflet, whereas phosphatidylcholine and sphingomyelin are more enriched on the outer leaflet. This asymmetry is maintained by flippases, floppases, the membrane skeleton, and cellular energy status. During apoptosis, platelet activation, calcium elevation, membrane injury, viral infection, or inflammatory stimulation, membrane lipid distribution can be rearranged. PS becomes exposed on the cell surface and subsequently participates in phagocytic clearance, coagulation complex assembly, intercellular recognition, and immune signal regulation.
Membrane Lipid Regulatory Step | Main Function | Related Molecules/Mechanisms | Experimental Focus |
Inward phospholipid flipping | Maintains PS on the inner leaflet | Flippase-related systems | Maintenance of membrane asymmetry under resting conditions |
Outward phospholipid transport | Promotes transport of some lipids to the outer leaflet | Floppase-related systems | Membrane lipid renewal, export, and changes in membrane composition |
Phospholipid scrambling | Bidirectionally disrupts membrane lipid asymmetry | PLSCR, TMEM16F, XKR-related systems | PS externalization, cell death, platelet procoagulation |
PS recognition | Recognizes exposed PS | Annexin V, phagocytosis-related receptors | Apoptosis detection, phagocytic clearance, and membrane injury assessment |
1.2 Functional Positioning of the PLSCR Family
The PLSCR family is usually referred to as a phospholipid scramblase-related protein family. Common research targets include PLSCR1, PLSCR2, PLSCR3, and PLSCR4. Among them, PLSCR1 has been studied more extensively. It is associated not only with membrane phospholipid disturbance and PS exposure, but also with interferon response, inflammatory responses, antiviral status, cell proliferation, and tumor cell stress. It should be noted that the PLSCR family is not the only execution system for PS externalization. In apoptosis, the Caspase-XKR8 axis is often more directly related to PS externalization. In platelet procoagulant activation, Ca²⁺-dependent TMEM16F/ANO6 is usually closer to the core mechanism. Therefore, the PLSCR family is more suitable for integrated analysis as a group of molecules involved in membrane phospholipid remodeling and cellular stress regulation.
2 PLSCR Family Members and Mechanistic Boundaries
2.1 PLSCR1
PLSCR1 is one of the most extensively studied members of the PLSCR family. It can localize to membrane-associated structures and can also participate in intracellular signaling regulation. PLSCR1 is commonly used to analyze changes in membrane phospholipid asymmetry, PS exposure, interferon-stimulated responses, inflammatory signaling, and tumor cell stress status. In experimental interpretation, increased PLSCR1 expression only indicates a change in protein level and does not directly prove enhanced membrane phospholipid scrambling. To demonstrate its involvement in PS externalization, Annexin V detection, membrane integrity detection, cell death indicators, localization analysis, and intervention experiments should be further combined.
2.2 PLSCR3
PLSCR3 is more closely associated with research on mitochondrial membranes, cellular stress, and cell death. Changes in the mitochondrial membrane lipid environment can affect mitochondrial function, membrane potential, cytochrome c release, and apoptotic signaling. Therefore, PLSCR3 is often discussed in the context of mitochondrial membrane lipid remodeling and apoptosis regulation. In experiments, PLSCR3 should not be simply equated with a plasma membrane PS externalization molecule. If mitochondrial death pathways are being studied, JC-1, mitochondrial ROS, cytochrome c, Caspase-9, BAX/BCL-2, and other indicators should be analyzed together.
2.3 PLSCR2 and PLSCR4
PLSCR2 and PLSCR4 have been less extensively studied than PLSCR1 in different tissue and cellular contexts, but they can still be included as molecules related to membrane lipid regulation and cellular stress. For these family members, expression changes alone often have limited explanatory power and are more suitable for combined interpretation with cell type, stimulation condition, membrane lipid status, and functional readouts. If PLSCR2 or PLSCR4 expression changes are observed in experiments, whether they have a causal relationship with PS externalization, inflammatory factor release, cell death mode, or tissue-specific function should be further evaluated.
Family Member | Main Research Association | Suitable Combined Detection Indicators | Interpretation Focus |
PLSCR1 | PS externalization, inflammation, interferon response, cellular stress | Annexin V, PI, IFN-related indicators, NF-κB, cell viability | Expression changes should be interpreted together with membrane localization and functional readouts |
PLSCR3 | Mitochondrial membrane lipid environment, cell death, oxidative stress | JC-1, mitochondrial ROS, Caspase-9, cytochrome c | More suitable for combined analysis with mitochondrial apoptotic pathways |
PLSCR2 | Membrane lipid regulation, tissue-related expression | PS externalization, cell status, tissue expression profile | Expression changes alone have limited explanatory power |
PLSCR4 | Membrane lipid disturbance, cell type-related function | Annexin V, cell death indicators, inflammatory indicators | Interpretation requires cell background and stimulation conditions |
3 PLSCR Family and Cell Death Research
3.1 PS Externalization in Apoptosis
During early apoptosis, PS can translocate from the inner leaflet of the membrane to the cell surface, serving as an important signal for phagocytes to recognize and clear apoptotic cells. Annexin V-positive/PI-negative staining is often used to indicate early apoptosis, whereas Annexin V-positive/PI-positive staining more commonly indicates late apoptosis or secondary necrosis. The PLSCR family can participate in apoptosis research as membrane lipid disturbance-related indicators, but apoptosis-related PS externalization is not necessarily directly driven by PLSCR proteins. If the experimental goal is to clarify the mechanism of apoptotic PS externalization, Caspase activity, XKR8, mitochondrial membrane potential, and membrane integrity should also be examined instead of only detecting PLSCR1 expression.
3.2 PS Exposure in Necrosis, Pyroptosis, and Membrane Injury
PS externalization does not occur only in classical apoptosis. In necrosis, pyroptosis, mechanical injury, or membrane repair processes, decreased membrane integrity or membrane lipid rearrangement can also cause PS exposure. In this context, Annexin V positivity may reflect membrane injury or membrane structural disorder rather than early apoptosis. Changes in the PLSCR family under these conditions are more appropriately interpreted as membrane stress or membrane lipid disturbance-related responses and should be evaluated together with PI, LDH release, GSDMD cleavage, Caspase-1 activity, cell morphology, and inflammatory factor release.
3.3 Mitochondria-Related Cell Death
PLSCR3 and other members show certain associations with mitochondrial membrane lipid status and cell death research. Mitochondrial membrane lipid remodeling may affect membrane potential, oxidative stress, cytochrome c release, and downstream Caspase activation. If the relationship between the PLSCR family and mitochondrial apoptosis is being studied, the two levels of plasma membrane PS externalization and mitochondrial membrane functional abnormality should be distinguished. The former can be detected by Annexin V/PI, whereas the latter is more suitable for analysis using JC-1, MitoSOX, ATP content, cytochrome c release, and Caspase-9.
4 PLSCR Family, Coagulation, and Platelet Activation
4.1 PS Externalization and Formation of Procoagulant Membrane Platforms
During coagulation, exposed PS provides a negatively charged membrane surface for coagulation factor complex assembly. After platelet activation, intracellular Ca²⁺ elevation can induce PS exposure and promote the formation of prothrombinase complexes and coagulation factor complexes on the membrane surface, thereby amplifying the coagulation response. This process is closely related to rapid disruption of membrane phospholipid asymmetry and is a core event in research on platelet procoagulant activity.
4.2 Mechanistic Distinction Between PLSCR and TMEM16F
In research on platelet procoagulant PS externalization, TMEM16F/ANO6 is usually an important Ca²⁺-dependent phospholipid scramblase. The PLSCR family can be used as membrane lipid disturbance-related background molecules or expression-regulated targets, but should not directly replace TMEM16F in explaining platelet procoagulant PS externalization. If the relationship between PLSCR1 and coagulation is being studied, it is recommended to position PLSCR1 as a membrane lipid remodeling- and cellular stress-related indicator, while also detecting Annexin V binding, Ca²⁺ levels, platelet activation markers, thrombin generation, and TMEM16F expression or function.
4.3 Interpretation of Coagulation Experiments
Enhanced Annexin V signal on platelets or cell surfaces indicates increased PS exposure, but does not directly demonstrate enhanced coagulation function. Whether an effective procoagulant platform is formed should be evaluated together with thrombin generation, coagulation factor binding, platelet activation status, and cell membrane integrity. If PI or other dead cell dyes are strongly positive, nonspecific PS exposure caused by cell damage needs to be excluded.
Research Question | Recommended Detection Combination | Interpretation Focus |
Platelet procoagulant activation | Annexin V, Ca²⁺ probe, P-selectin, thrombin generation | Distinguishes platelet activation, PS externalization, and procoagulant function |
Ca²⁺-dependent PS externalization | TMEM16F/ANO6, Ca²⁺ flux, Annexin V | Determines Ca²⁺-driven membrane lipid scrambling |
PLSCR-related expression changes | PLSCR1/PLSCR family antibodies, qPCR, WB, IF | Determines expression and localization changes after stimulation |
Cell injury interference | PI, 7-AAD, LDH release | Excludes nonspecific PS exposure caused by membrane rupture |
5 PLSCR Family and Inflammatory/Immune Signaling
5.1 PLSCR1 and Interferon Response
PLSCR1 is closely related to interferon stimulation and antiviral responses and often changes in expression under viral infection, IFN stimulation, or innate immune activation. In this context, PLSCR1 should not be understood only as a membrane phospholipid scrambling-related molecule, but also as part of cellular stress and host defense responses. In research, PLSCR1 can be analyzed together with IFN-stimulated genes, STAT1/STAT2, IRF pathways, viral replication levels, and inflammatory factors.
5.2 PLSCR Family, NF-κB, and Inflammatory Factor Release
Inflammatory stimulation can alter membrane lipid composition, the membrane receptor microenvironment, and cell death modes, and may also be accompanied by changes in PLSCR family expression or localization. PLSCR1 changes can be analyzed together with NF-κB signaling and levels of inflammatory factors such as TNF-α, IL-6, and IL-1β, but cannot independently prove activation of inflammatory pathways. If increased PLSCR1 is observed together with increased Annexin V positivity, further assessment is needed to determine whether this is a composite result caused by inflammatory stress, apoptosis, pyroptosis, or membrane injury.
5.3 Membrane Lipid Remodeling in Infection Models
Viruses, bacterial toxins, or inflammatory mediators can all induce membrane lipid remodeling and cell death. In infection models, PS exposure may affect viral entry, cell-to-cell spread, phagocytic clearance, and immune recognition. In this type of research, PLSCR1 is more suitable as a linking indicator among membrane lipid remodeling, interferon response, and cellular stress. Experimental design should avoid detecting only PLSCR1 expression and should simultaneously observe pathogen stimulation intensity, cell death mode, inflammatory factors, and membrane lipid status.
6 Experimental Design and Result Interpretation
6.1 Distinguishing Expression, Localization, and Function
In PLSCR family research, expression changes, subcellular localization changes, and functional changes are not the same concept. WB or qPCR showing increased PLSCR1 only indicates changes at the protein or transcriptional level. Immunofluorescence can help determine whether membrane localization or intracellular distribution has changed. Annexin V, lipid probes, or membrane model experiments are closer to evaluating PS externalization or membrane lipid scrambling function. If direct involvement of PLSCR1 in a process needs to be demonstrated, overexpression, knockdown, mutant constructs, or inhibitory conditions should be used for causal validation.
6.2 Distinguishing PS Externalization from Cell Death Mode
PS externalization is a phenomenon, not a specific mode of cell death. Apoptosis, necrosis, pyroptosis, platelet activation, and plasma membrane injury can all show PS exposure. Experiments should at least combine membrane integrity and death pathway indicators. Annexin V is used to detect PS externalization; PI or 7-AAD is used to determine membrane injury; Caspase-3/7 is used to determine apoptosis; GSDMD cleavage and IL-1β release are used to determine pyroptosis; and LDH release can indicate membrane rupture or cell injury.
6.3 Application Boundaries of Recombinant PLSCR1 Protein
Recombinant Human PLSCR1 Protein is more suitable for detection system establishment, antibody validation, WB positive control, ELISA coating, protein interaction studies, and method development. Since membrane lipid scrambling function depends on membrane environment, lipid composition, protein conformation, Ca²⁺ status, and intracellular regulatory conditions, a single recombinant PLSCR1 protein cannot directly represent complete scramblase activity on the cell membrane. If phospholipid transport function is being studied, cell models, membrane systems, or liposome reconstitution experiments should be selected and combined with functional readouts of PS externalization.
7 Common Questions and Result Interpretation
7.1 Does Increased PLSCR1 Indicate Enhanced PS Externalization?
No. Increased PLSCR1 may be related to membrane lipid disturbance, interferon stimulation, inflammatory responses, oxidative stress, or changes in cell proliferation status. Whether PS externalization occurs needs to be judged together with Annexin V detection, membrane integrity indicators, and cell status.
7.2 Does Annexin V Positivity Always Indicate Early Apoptosis?
Annexin V positivity indicates PS exposure on the cell surface, but PS externalization does not occur only in early apoptosis. Platelet activation, cell injury, extracellular vesicle release, and inflammatory stimulation can also cause PS exposure. Early apoptosis is more strongly supported only when cells are Annexin V-positive/PI-negative and show Caspase activation or typical apoptotic morphology.
7.3 Can PLSCR1, TMEM16F, and XKR8 Replace Each Other?
They should not be used as substitutes for one another. PLSCR1 is more suitable for research on membrane lipid disturbance, inflammation, and stress. TMEM16F is more suitable for Ca²⁺-dependent PS externalization and platelet procoagulation research. XKR8 is more suitable for Caspase-dependent apoptotic PS externalization research. These molecules can be detected together, but their interpretation focuses are different.
7.4 Can Recombinant PLSCR1 Protein Be Used for Scramblase Activity Experiments?
Recombinant PLSCR1 protein alone should not be directly equated with scramblase activity on the cell membrane. It is more suitable for methodological applications such as antibody validation, positive control, ELISA coating, and protein interaction studies. Scramblase functional research needs to consider membrane environment, lipid substrate, Ca²⁺ conditions, protein localization, and cellular state.
7.5 How Should PLSCR1 Changes Be Interpreted in Inflammation Models?
Changes in PLSCR1 in inflammation models can indicate involvement of cellular stress and immune responses, but they cannot independently demonstrate PS externalization, cell death, or inflammatory pathway activation. A more reasonable approach is to jointly detect IFN-related indicators, NF-κB signaling, inflammatory factors, cell viability, Annexin V, and PI to determine whether PLSCR1 changes occur in the context of inflammatory response, membrane disturbance, or cell death.
8 Product Selection Related to the PLSCR Family, PS Externalization, and Cell Death/Inflammatory Signaling Research
Product Module | Cat. No. | Product Name | Grade & Purity | Application Positioning |
PLSCR family core research | Recombinant Human PLSCR1 Protein | ≥95%(SDS-PAGE) | PLSCR1 detection system establishment, antibody validation, WB positive control, ELISA coating, and protein interaction studies | |
PLSCR family core research | PLSCR1 Human Pre-designed siRNA Set A |
| PLSCR1 knockdown for validating its role in PS externalization, inflammatory stress, or cell death | |
PLSCR family core research | PLSCR3 Human Pre-designed siRNA Set A |
| PLSCR3 knockdown for analyzing mitochondrial membrane lipid disturbance and cell death mechanisms | |
PLSCR family core research | PLSCR4 Human Pre-designed siRNA Set A |
| PLSCR4 knockdown for supplementary functional analysis of PLSCR family members | |
PLSCR family detection | Recombinant PLSCR3 Antibody | Recombinant, ExactAb™, validated, see COA | Detects PLSCR3 expression and assists in analyzing mitochondrial membrane lipid remodeling and cell death-related changes | |
PS externalization detection | Annexin V Binding Buffer (10x) | Sterile-filtered, suitable for immunofluorescence (IF), BioReagent, for microscopy, 10× | Supporting buffer for Annexin V staining, ensuring Ca²⁺-dependent PS binding conditions | |
PS externalization detection | Annexin V Binding Buffer (1×) | Sterile-filtered, suitable for immunofluorescence (IF), BioReagent, for microscopy, 1× | Ready-to-use Annexin V binding buffer for apoptosis and PS externalization detection | |
PS externalization detection | Annexin V-AF488 | Suitable for immunofluorescence (IF), BioReagent, biological stain, for microscopy, 5 μL/test | Detects cell-surface PS externalization in the green channel, suitable for IF or flow cytometry-related experiments | |
PS externalization detection | Annexin V-AF647 | Suitable for immunofluorescence (IF), BioReagent, biological stain, for microscopy, 5 μL/test | Detects PS externalization in the far-red channel, suitable for multicolor combined analysis | |
PS externalization detection | Annexin V-APC | Suitable for immunofluorescence (IF), BioReagent, biological stain, for microscopy, 5 μL/test | Detects PS externalization in the APC channel, suitable for flow cytometry | |
PS externalization detection | Annexin V-FITC | Suitable for immunofluorescence (IF), BioReagent, biological stain, for microscopy, 5 μL/test | Detects early apoptosis-related PS externalization in the FITC channel | |
PS recognition-related protein | Recombinant Human Annexin V/ANXA5 Protein | Animal-free, carrier-free, bioactive, ActiBioPure™, His tag, ≥95%(SDS-PAGE) | Annexin V-related methodological validation, protein experiments, and PS binding system research | |
PS recognition-related protein | Recombinant Human Annexin V/ANXA5 Protein | Carrier-free, ≥95%(SDS-PAGE) | Annexin V detection system establishment and control experiments | |
Annexin V detection validation | Annexin V/ANXA5 Mouse mAb | Carrier-free, ExactAb™, azide-free, validated, high performance, see COA | Detects Annexin V/ANXA5 for validating PS recognition tools or related protein expression | |
Early/late apoptosis staging | Annexin V- AF488/PI Apoptosis Detection Kit | Suitable for immunofluorescence (IF), BioReagent, ready-to-use, biological stain, for microscopy | Distinguishes early apoptosis, late apoptosis/secondary necrosis, and viable cells | |
Early/late apoptosis staging | Annexin V- AF647/PI Apoptosis Detection Kit | Suitable for immunofluorescence (IF), BioReagent, ready-to-use, biological stain, for microscopy | Combines far-red Annexin V with PI for multicolor apoptosis analysis | |
Early/late apoptosis staging | Annexin V- APC/7-AAD Apoptosis Detection Kit | Bioactive, ready-to-use, biological stain, for Fluorescence analysis, for microscopy | Uses Annexin V and 7-AAD to distinguish PS externalization from loss of membrane integrity | |
Early/late apoptosis staging | Annexin V-FITC/PI Apoptosis Detection Kit | Suitable for immunofluorescence (IF), BioReagent, biological stain, for microscopy | Classical FITC/PI combination for apoptosis staging and PS externalization analysis | |
Integrated apoptosis/necrosis/healthy cell detection | All-in-One Apoptotic, Necrotic and Healthy Cell Comprehensive Status Enhanced Detection Kit (Annexin V-APC, 7-AAD, Hoechst 33342) | BioReagent, biological stain, for Fluorescence analysis, for microscopy, sterile | Simultaneously analyzes PS externalization, membrane integrity, and nuclear status | |
Integrated apoptosis/necrosis/healthy cell detection | All-in-One Apoptotic, Necrotic and Healthy Cell Comprehensive Status Enhanced Detection Kit (Annexin V-R-PE, Draq 7, Hoechst 33342) | BioReagent, biological stain, for Fluorescence analysis, for microscopy, sterile | Uses multiple indicators to distinguish apoptosis, necrosis, and healthy cell states | |
Caspase-dependent apoptosis detection | Live Cell Caspase-3/7 Activity and Annexin V Dual Apoptosis Detection Kit (LumiDye™ 488 Caspase-3/7, LumiDye™ 594-Annexin V, Hoechst 33342) | BioReagent, biological stain, for Fluorescence analysis, for microscopy, sterile | Simultaneously detects Caspase-3/7 activity, PS externalization, and nuclear morphology | |
Caspase-dependent apoptosis detection | Live Cell Caspase-3/7 Activity and Annexin V Dual Apoptosis Detection Kit (LumiDye™ 488 Caspase-3/7, LumiDye™ 647-Annexin V, EthD Gold) | BioReagent, biological stain, for Fluorescence analysis, for microscopy, sterile | Jointly determines Caspase activation, PS externalization, and membrane injury | |
Caspase-dependent apoptosis detection | Caspase 3/7 Activity Assay Kit | BioReagent | Detects effector Caspase activity and assists in determining apoptotic pathway activation | |
Caspase protein validation | Recombinant Human Caspase-3 Protein | ≥90%(SDS-PAGE) | Caspase-3 antibody validation, positive control, and methodological establishment | |
Caspase protein validation | Recombinant Human Caspase-8 Protein | Carrier-free, His tag, ≥90%(SDS-PAGE) | Caspase-8 detection system establishment and extrinsic apoptosis pathway validation | |
Caspase protein validation | Recombinant Human Caspase-9 Protein | Carrier-free, His tag, ≥90%(SDS-PAGE) | Caspase-9 detection system establishment and mitochondrial apoptosis pathway validation | |
Caspase pathway antibody | Caspase 3 Mouse mAb | Carrier-free, ExactAb™, azide-free, validated, high performance, PBS Only, ≥95%(SDS-PAGE), 1.0 mg/mL | Detects Caspase-3 expression and assists in determining the apoptotic execution stage | |
Caspase pathway antibody | Cleaved Caspase 8 Antibody | KD Validation | Detects Cleaved Caspase-8 and determines extrinsic apoptosis pathway activation | |
Caspase pathway antibody | Recombinant cleaved Caspase-9 Antibody | KD Validation | Detects Cleaved Caspase-9 and analyzes mitochondrial apoptosis pathway activation | |
Caspase pathway intervention | Z-DEVD-FMK | ≥98% | Inhibits Caspase-3 to validate whether PS externalization or cell death depends on effector Caspases | |
Caspase pathway intervention | Z-IETD-FMK | ≥99% | Inhibits Caspase-8 to analyze the contribution of the extrinsic apoptosis pathway | |
Caspase pathway intervention | Z-LEHD-FMK | ≥98% | Inhibits Caspase-9 to analyze the contribution of the mitochondrial apoptosis pathway | |
Caspase pathway intervention | Boc-D-FMK | ≥90% | Pan-Caspase inhibition for validating Caspase dependence of cell death and PS externalization | |
Caspase pathway intervention | PAC-1 | Moligand™, ≥98% | Activates Caspase-3 and is used to construct apoptosis induction or mechanistic validation models | |
Apoptotic PS externalization mechanism | XKR8 Human Pre-designed siRNA Set A |
| XKR8 knockdown for validating Caspase-dependent PS externalization mechanisms | |
Ca²⁺-dependent PS externalization | ANO6 Human Pre-designed siRNA Set A |
| ANO6/TMEM16F knockdown for studying Ca²⁺-dependent PS externalization and procoagulant membrane platform formation | |
Ca²⁺-dependent PS externalization | Human Anoctamin 6 (ANO6) ELISA Kit | BioReagent | Quantitatively detects ANO6 levels and assists in analyzing Ca²⁺-dependent membrane phospholipid scrambling-related changes | |
IFN/antiviral inflammatory signaling | Recombinant IFN-alpha Antibody | Carrier-free, recombinant, ExactAb™, azide-free, validated, see COA | Detects IFN-α-related changes and analyzes the relationship between PLSCR1 and interferon response | |
IFN/antiviral inflammatory signaling | Recombinant IFNγ Antibody | Carrier-free, recombinant, ExactAb™, low endotoxin, azide-free, validated, PBS Only, ≥99%(SEC-HPLC), see COA | Detects IFNγ-related inflammation and immune activation signals | |
IFN/STAT pathway | Recombinant Phospho-STAT1 (S727) Antibody | KD Validation | Detects STAT1 phosphorylation and analyzes IFN-related signal activation | |
IFN/STAT pathway | Recombinant STAT1 Antibody | Recombinant, ExactAb™, KD Validation, validated, see COA | Detects total STAT1 and assists in interpreting interferon responses | |
IFN/STAT pathway | Recombinant STAT2 Antibody | KO Validation | Detects STAT2 and assists in analyzing IFN-I-related pathways | |
IFN/STAT pathway | Recombinant Phospho-STAT3 (Tyr705) Antibody | KD Validation | Detects STAT3 Tyr705 phosphorylation and analyzes inflammatory signaling and cellular stress responses | |
IFN/STAT pathway | Recombinant STAT3 Antibody | Recombinant, ExactAb™, KD Validation, validated, see COA | Detects total STAT3 for inflammatory and cellular stress pathway analysis | |
NF-κB inflammatory signaling | Human Nuclear Factor Kappa B (NF-κB) ELISA Kit | BioReagent | Quantitatively detects human NF-κB levels and analyzes inflammatory pathway activation | |
NF-κB inflammatory signaling | Mouse Nuclear Factor Kappa B (NF-κB) ELISA Kit | BioReagent | Detects NF-κB in mouse samples for inflammation models | |
NF-κB inflammatory signaling | Rat Nuclear Factor Kappa B (NF-κB) ELISA Kit | BioReagent | Detects NF-κB in rat samples for inflammation or injury models | |
NF-κB binding activity detection | EMSA Probe NF-κB | 10 μM | Detects NF-κB DNA-binding activity and analyzes transcriptional regulation of inflammatory signaling | |
NF-κB binding activity detection | Biotin-labeled EMSA probe-NF-κB | 0.2 μM | Biotin-labeled EMSA probe for detecting NF-κB binding activity | |
NF-κB pathway intervention | DMAPT | Moligand™, ≥98% | Inhibits NF-κB to validate whether PLSCR1 changes are related to inflammatory signaling | |
NF-κB pathway intervention | AP-1/NF-κB activation inhibitor 1 | ≥99% | Inhibits AP-1/NF-κB activation for inflammatory signaling intervention | |
NF-κB pathway intervention | NF-κB-IN-1 | ≥99% | NF-κB pathway inhibition to validate the effect of inflammatory signaling on PLSCR-related changes |
For more related articles, please see below:
[1] Experiments for the morphological evaluation of cell death
[2] Experiments on biochemical analysis of cell death
[3] Staining Principles and Methods for Cell Death, Proliferation, and Metabolic Viability
危险品化学品经营许可证(带存储)